Governance AbbVie Inc.

ABBV

US00287Y1091

Pharmaceuticals

Market Closed - Nyse Other stock markets 21:00:03 13/02/2026 GMT			5-day change	1st Jan Change
231.50 ^USD	+1.76%		+3.61%	+1.32%

02-13	China Medical University Hospital Collaborates with Ever Supreme Bio Technology to Develop Exosome Platform	CI
02-12	AbbVie sues US health agency over Botox price controls	RE

Executive Committee: AbbVie Inc.

Manager

Positions heldSince

Robert Michael

55 year

Chief Executive Officer

30/06/2024

Roopal Thakkar

Chief Tech/Sci/R&D Officer

31/12/2002

Perry Siatis

General Counsel	16/10/2022
Corporate Secretary	16/10/2022

Azita Saleki-Gerhardt

62 year

Chief Operating Officer

30/06/2023

Scott Reents

59 year

Director of Finance/CFO

22/06/2022

Tim Richmond

59 year

Human Resources Officer

31/12/2012

Liz Shea

Investor Relations Contact

31/12/2012

Composition of the Board of Directors: AbbVie Inc.

Director

CommitteesSince

Robert Michael

55 year

Chairman

30/06/2025

Roxanne Austin

65 year

Audit Committee
Governance Committee
Compensation Committee Chair	31/12/2012
Audit Committee Chair	12/05/2021
Finance Committee	12/05/2021
Governance Committee Chair	30/11/2025
Nominating Committee Chair	30/11/2025

Edward Rapp

68 year

Audit Committee	31/12/2012
Governance Committee
Nominating Committee
Compensation Committee	19/08/2021
Audit Committee Chair	19/08/2021

Rebecca Roberts

73 year

Compensation Committee	12/02/2015
Governance Committee Chair	31/12/2010
Governance Committee
Nominating Committee

Thomas Freyman

71 year

Compensation Committee	07/05/2020
Audit Committee Chair	07/05/2020
Governance Committee Chair
Nominating Committee Chair

Frederick Waddell

72 year

Executive Committee
Compensation Committee Chair
Compensation Committee
Audit Committee Chair

Robert Alpern

75 year

Governance Committee	30/09/2013
Nominating Committee	30/09/2013
Compensation Committee

Brett Hart

56 year

Governance Committee	31/12/2015
Nominating Committee	31/12/2015
Compensation Committee Chair

Thomas Falk

67 year

Governance Committee Chair	01/05/2024
Nominating Committee Chair	01/05/2024
Audit Committee	08/05/2025

William Burnside

74 year

Executive Committee
Audit Committee	31/12/2012

Melody Meyer

68 year

Compensation Committee
Audit Committee	31/12/2016

Jennifer Davis

54 year

Governance Committee	10/10/2023
Nominating Committee	10/10/2023

Susan Quaggin

62 year

Director/Board Member	10/10/2023
Independent Dir/Board Member	10/10/2023

Latest Appointments: AbbVie Inc.

01-29	Definium Therapeutics Appoints Roger Adsett to Board of Directors, Effective from January 29, 2025	CI
01-12	FTI Consulting, Inc. Appoints Dan Scorpio and Heather Wilson as Senior Managing Directors	CI
01-12	Analyst recommendations: Exxon Mobil, AbbVie, Eli Lilly, JD Sports…
01-08	Sector Update: Health Care Stocks Retreat Late Afternoon	MT
01-08	Sector Update: Health Care Stocks Lower in Afternoon Trading	MT
01-08	PRESS DIGEST-Wall Street Journal - January 8	RE
01-07	SAB Biotherapeutics, Inc. Announces Board Changes ,Effective January 7, 2026	CI

More news

Former Officers and Directors: AbbVie Inc.

Insider

Positions held

SinceUntil

Richard Gonzalez

Chief Executive Officer	31/12/2012	30/06/2024
Chairman	31/12/2012	30/06/2025

Glenn Tilton

Director/Board Member	31/12/2012	30/06/2025
Independent Dir/Board Member	31/12/2012	30/06/2025

Kevin Buckbee

Comptroller/Controller/Auditor

28/02/2023

28/02/2025

Carrie Strom

Corporate Officer/Principal

07/05/2020

31/01/2025

Thomas Hudson

Chief Tech/Sci/R&D Officer	30/06/2019	09/07/2024
Corporate Officer/Principal	31/12/2015	30/06/2019

Jane Woo

Public Communications Contact

31/03/2021

31/03/2024

Katherine Rielly-Gauvin

Corporate Officer/Principal

31/12/2012

30/06/2023

Neil Gallagher

Chief Tech/Sci/R&D Officer	31/12/2019	31/03/2023
Corporate Officer/Principal	31/10/2017	31/12/2019

Frank Benenati

Public Communications Contact

31/03/2021

31/03/2023

Henry Gosebruch

Corporate Officer/Principal

30/11/2015

31/01/2023

Chris Boone

Corporate Officer/Principal

01/01/2023

Mohamed Zaki

Corporate Officer/Principal

31/08/2018

30/11/2022

Matthew Farber

Corporate Officer/Principal

31/05/2022

Michael Severino

Chief Tech/Sci/R&D Officer	31/05/2014	16/12/2018
President	16/12/2018	30/05/2022

Edward Liddy

Director/Board Member	31/12/2012	10/05/2022
Independent Dir/Board Member	31/12/2012	10/05/2022

Kate C. Liebelt

Corporate Officer/Principal

31/05/2020

29/04/2022

Todd D. Bosse

Investor Relations Contact

30/11/2021

Nataskia Lampe

Corporate Officer/Principal

29/02/2012

31/07/2021

Carlos Alban

Director/Board Member	16/12/2018	28/02/2021
Corporate Officer/Principal	31/12/2012	28/02/2021

Jose-Carlos Gutiérrez-Ramos

Corporate Officer/Principal

31/01/2020

31/12/2020

Adelle Infante

Public Communications Contact

30/11/2020

Janet Hammond

Corporate Officer/Principal

31/10/2016

31/07/2020

Vusi Moyo

Public Communications Contact

31/03/2020

Ronald O. Robison

General Counsel	13/01/2013	-
Corporate Officer/Principal	-	31/03/2020

Myra Rosario Herrle

Corporate Officer/Principal

31/07/2014

29/02/2020

Frank A. Jaeger

Sales & Marketing

31/12/2013

31/07/2019

Nadia Dac

Corporate Officer/Principal

30/11/2014

28/02/2019

Scott Brun

Corporate Officer/Principal

28/02/2019

John Westwater

Director/Board Member

31/03/2018

30/12/2018

Jim Sullivan

Private Equity Investor

31/12/2012

30/11/2018

Graig Suvannavejh

Corporate Officer/Principal

28/02/2017

30/06/2018

Melanie Gloria

Corporate Officer/Principal

31/07/2014

30/06/2018

Elizabeth Thompson

Chief Tech/Sci/R&D Officer

31/08/2015

30/04/2018

Paul Schwichtenberg

Corporate Officer/Principal

30/09/2013

31/03/2018

Gary Gordon

Corporate Officer/Principal

31/12/2012

31/03/2018

Mark Stenhouse

Corporate Officer/Principal

30/09/2016

28/02/2018

Sujay Kango

Corporate Officer/Principal

31/12/2016

31/01/2018

Shao Lee Lin

Corporate Officer/Principal

31/03/2015

30/11/2017

Thomas A. Hurwich

Comptroller/Controller/Auditor

27/02/2017

Sharon Curran

Corporate Officer/Principal

31/12/2011

31/12/2016

Francisco Velasco

Corporate Officer/Principal

31/05/2009

31/05/2016

Roy S. Roberts

Director/Board Member	31/12/2012	05/05/2016
Independent Dir/Board Member	31/12/2012	05/05/2016

Renee Tannenbaum

Corporate Officer/Principal

30/09/2012

31/12/2015

Rita Jain

Corporate Officer/Principal

31/12/2012

31/12/2015

Maria Rivas

Chief Tech/Sci/R&D Officer

31/07/2012

30/11/2015

Peter Heerma

Corporate Officer/Principal

30/11/2012

31/10/2015

David H. Donabedian

Corporate Officer/Principal

31/07/2015

Paul Wierbicki

General Counsel

28/02/2014

30/04/2015

Jennifer Mound Smoter

Public Communications Contact

31/07/2012

28/02/2015

Barry Regan

Chief Operating Officer	31/12/2012	28/02/2015
Corporate Officer/Principal	-	-

Alysa Spittle

Public Communications Contact

31/12/2012

31/12/2014

Gary Winer

Corporate Officer/Principal

31/03/2014

31/12/2014

Steven N. Gersten

Compliance Officer

31/12/2014

Mohit Rawat

Corporate Officer/Principal

31/07/2013

30/04/2014

Lily Chang

Private Equity Analyst

31/12/2012

31/12/2013

Lars Kielhorn

Corporate Officer/Principal

31/12/2010

31/12/2013

John Leonard

Chief Tech/Sci/R&D Officer

31/12/2012

31/12/2013

Donald Frail

Corporate Officer/Principal

31/12/2013

Jose Rivera

Compliance Officer

31/12/2012

31/08/2013

George Avgerinos

Corporate Officer/Principal

30/06/2008

30/06/2013

Laura Schumacher

General Counsel	31/12/2012	-
Corporate Secretary	09/02/2014	16/10/2022

Greg W. Linder

Director/Board Member

30/12/2012

Sharon Greenlees

Investor Relations Contact	31/12/2015	31/12/2017
Corporate Officer/Principal	31/12/2017	-

Björn Cochlovius

Corporate Officer/Principal

Ann Tomlin

Human Resources Officer

Gregory Miley

Public Communications Contact	-	-
General Counsel	-	-

Larry Peepo

Investor Relations Contact

William Chase

Chief Administrative Officer	18/10/2018	-
Director of Finance/CFO	-	18/10/2018

Star Seyedkazemi

Corporate Officer/Principal

David Laskow-Pooley

Director/Board Member

Paulo Vega

Corporate Officer/Principal

Kimberly Davis-Wells

Corporate Officer/Principal

Karen Hale

Compliance Officer

Glenn S. Warner

Corporate Officer/Principal

Jordan Dubow

Corporate Officer/Principal

Li Malmberg

Corporate Officer/Principal

Youssef Bennani

Corporate Officer/Principal

Derrell Porter

Sales & Marketing

Douglas Feltner

Corporate Officer/Principal

Denelle Waynick

General Counsel

Christopher Kurtz

Corporate Officer/Principal

James P. Sullivan

Corporate Officer/Principal

Gentry Lassiter

Public Communications Contact

Karl G. Trass

Corporate Officer/Principal

Barbara McGovern

Corporate Officer/Principal

Saeed Motahari

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	18
Female	6

Of which Executive Committee

Male	6
Female	1

Of which Directors

Male	9
Female	4

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (76.4%), Germany (2.6%), Japan (2%), Canada (1.9%), China (1.6%), France (1.4%), Spain (1%), the United Kingdom (0.9%), Italy (0.9%), Brazil (0.8%), Australia (0.8%), and other (9.7%).

Employees

55,000

Sector

Pharmaceuticals

Calendar

04-23 - Q1 2026 Earnings Release (Projected)

More about the company